Q3 Asset Management Abb Vie Inc. Transaction History

Q3 Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $900,722 - $1.15 Million	-6,545 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $75,756 - $93,992	-574 Reduced 8.06%	6,545 $1.06 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $764,794 - $967,685	7,119 New	7,119 $964,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Q3 Asset Management, based on Form 13F filings with the SEC.

Stay updated on Q3 Asset Management with notifications on news.